Therapeutic Outcomes and Efficacy of Intralesional 5-Fluorouracil in the Management of Cutaneous Warts: A Multi-Centric Prospective Cohort Study
Dermatology and Dermatitis · 28.12.2023 · 9 (1) · 01-07
DOI: 10.31579/2578-8949/211 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Dermatology and Dermatitis, online erschienen am 28.12.2023. Verfasst von Ahmed Adel Ali Ali * und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Cutaneous warts are common viral skin infections caused by human papillomavirus (HPV) and often present therapeutic challenges due to recurrence and resistance to conventional treatments. Intralesional therapies, including 5-fluorouracil (5-FU), have emerged as promising alternatives, demonstrating targeted cytotoxic effects on infected keratinocytes. Previous randomized and comparative studies have reported favorable clearance rates and acceptable safety profiles for intralesional 5-FU in treating different wart types. Objective: to evaluate the efficacy and safety of intralesional 5-FU in the treatment of cutaneous warts and to assess treatment response, side effects, and recurrence rates.
Methods
A multi-centric prospective cohort study was conducted on patients with clinically diagnosed warts at a dermatology outpatient clinic. This multicenter study was conducted across three dermatology centers in Cairo, Egypt. Patients received intralesional 5-FU (50 mg/mL) injections every two weeks for up to six sessions. Clinical evaluation included wart type, number, and response to treatment, categorized as complete, partial, or no response.
Results
Sixty patients were included, with a mean age of 29.5 ± 8.8 years. The majority had plantar warts (56.7%). Complete response was achieved in 83.3% of patients, while 16.7% showed partial response. No recurrence was observed among completely cured patients. Pain was reported in all patients (100%), while mild erythema occurred in 13.3%. A significant association was found between treatment response and number of sessions (p = 0.006).
Conclusions
Intralesional 5-FU is an effective and safe treatment modality for cutaneous warts, with high clearance rates and minimal recurrence. Despite mild local side effects, it represents a valuable therapeutic option, particularly for resistant cases.
Zitieren
APA
*, A. A. A. A., Atef, A., & Saber, F. (2023). Therapeutic Outcomes and Efficacy of Intralesional 5-Fluorouracil in the Management of Cutaneous Warts: A Multi-Centric Prospective Cohort Study. Dermatology and Dermatitis, 9(1), 01-07. https://doi.org/10.31579/2578-8949/211
Vancouver
* AAAA, Atef A, Saber F. Therapeutic Outcomes and Efficacy of Intralesional 5-Fluorouracil in the Management of Cutaneous Warts: A Multi-Centric Prospective Cohort Study. Dermatology and Dermatitis. 2023;9(1):01-07. doi:10.31579/2578-8949/211
BibTeX
@article{2023,
author = {*, Ahmed Adel Ali Ali and Atef, Aliaa and Saber, Fatema},
title = {Therapeutic Outcomes and Efficacy of Intralesional 5-Fluorouracil in the Management of Cutaneous Warts: A Multi-Centric Prospective Cohort Study},
journal = {Dermatology and Dermatitis},
year = {2023},
volume = {9},
number = {1},
pages = {01--07},
doi = {10.31579/2578-8949/211}
}
EUVIMED